{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:03Z","timestamp":1761100923836},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1007\/bf02782200","type":"journal-article","created":{"date-parts":[[2008,1,4]],"date-time":"2008-01-04T09:04:50Z","timestamp":1199437490000},"page":"333-336","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide"],"prefix":"10.1007","volume":"17","author":[{"given":"MJ","family":"Jenner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"INM","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AZ","family":"Rohatiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SM","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AC","family":"Newland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JD","family":"Cavenagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,1]]},"reference":[{"key":"BF02782200_CR1","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation.Blood 1995;85: 3005\u20133020.","journal-title":"Blood"},{"key":"BF02782200_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","volume":"22","author":"JH Lee","year":"1998","unstructured":"Lee JHet al. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.Bone Marrow Transplant 1998;22: 883\u2013888.","journal-title":"Bone Marrow Transplant"},{"issue":"3\u20134","key":"BF02782200_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/10428199709114163","volume":"25","author":"EM Faioni","year":"1997","unstructured":"Faioni EM, Mannucci PM. Venocclusive disease of the liver after bone marrow transplantation: the role of hemostasis.Leuk Lymphoma 1997;25(3\u20134): 233\u2013245.","journal-title":"Leuk Lymphoma"},{"key":"BF02782200_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.bmt.1700985","volume":"20","author":"JD Morris","year":"1997","unstructured":"Morris JDet al. Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation.Bone Marrow Transplant 1997;20: 871\u2013878.","journal-title":"Bone Marrow Transplant"},{"key":"BF02782200_CR5","first-page":"443","volume":"17","author":"DF Patton","year":"1996","unstructured":"Patton DFet al. Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate.Bone Marrow Transplant 1996;17: 443\u2013447.","journal-title":"Bone Marrow Transplant"},{"key":"BF02782200_CR6","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1182\/blood.V92.12.4568","volume":"92","author":"H Hagglund","year":"1998","unstructured":"Hagglund Het al. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.Blood 1998;92: 4568\u20134572.","journal-title":"Blood"},{"key":"BF02782200_CR7","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","volume":"79","author":"M Attal","year":"1992","unstructured":"Attal Met al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial.Blood 1992;79: 2834\u20132840.","journal-title":"Blood"},{"key":"BF02782200_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","volume":"84","author":"SI Bearman","year":"1993","unstructured":"Bearman SIet al. A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation.Br J Haematol 1993;84: 724\u2013730.","journal-title":"Br J Haematol"},{"key":"BF02782200_CR9","first-page":"367","volume":"10","author":"JH Essell","year":"1992","unstructured":"Essell JHet al. Pilot trial of prophylactic ursodiol to decrease the incidence of veno- occlusive disease of the liver in allogeneic bone marrow transplant patients.Bone Marrow Transplant 1992;10: 367\u2013372.","journal-title":"Bone Marrow Transplant"},{"issue":"12 Pt 1","key":"BF02782200_CR10","first-page":"971","volume":"128","author":"JH Essell","year":"1998","unstructured":"Essell JHet al. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.Ann Intern Med 1998;128(12 Pt 1): 971\u2013981.","journal-title":"Ann Intern Med"},{"key":"BF02782200_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","volume":"74","author":"E Gluckman","year":"1990","unstructured":"Gluckman Eet al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.Br J Haematol 1990;74: 277\u2013281.","journal-title":"Br J Haematol"},{"key":"BF02782200_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","volume":"47","author":"L Marsa-Vila","year":"1991","unstructured":"Marsa-Vila Let al. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation.Eur J Haematol 1991;47: 346\u2013354.","journal-title":"Eur J Haematol"},{"key":"BF02782200_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","volume":"61","author":"R Or","year":"1996","unstructured":"Or Ret al. Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.Transplantation 1996;61: 1067\u20131071.","journal-title":"Transplantation"},{"key":"BF02782200_CR14","first-page":"185","volume":"18","author":"J Rosenthal","year":"1996","unstructured":"Rosenthal Jet al. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.Bone Marrow Transplant 1996;18: 185\u2013191.","journal-title":"Bone Marrow Transplant"},{"key":"BF02782200_CR15","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","volume":"89","author":"C Salat","year":"1997","unstructured":"Salat Cet al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.Blood 1997;89: 2184\u20132188.","journal-title":"Blood"},{"key":"BF02782200_CR16","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1182\/blood.V80.10.2458.2458","volume":"80","author":"SI Bearman","year":"1992","unstructured":"Bearman SI, Shuhart MC, Hinds MS, McDonald GB. Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation.Blood 1992;80: 2458\u20132462.","journal-title":"Blood"},{"key":"BF02782200_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","volume":"89","author":"SI Bearman","year":"1997","unstructured":"Bearman SI, Lee JL, Baron AE, McDonald GB. Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients.Blood 1997;89: 1501\u20131506.","journal-title":"Blood"},{"key":"BF02782200_CR18","first-page":"737","volume":"92","author":"PG Richardson","year":"1998","unstructured":"Richardson PGet al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.Blood 1998;92: 737\u2013744.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02782200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02782200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02782200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02782200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:19:05Z","timestamp":1702606745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02782200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["BF02782200"],"URL":"https:\/\/doi.org\/10.1007\/bf02782200","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"30 November 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}